Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, As Represented By”

2,152 pharma patents match "The United States of America, As Represented By" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,152
Index total 30,257
Page 44 / 90

Quick answer

This filtered view shows 2,152 pharmaceutical patents matching "The United States of America, As Represented By" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,152 results for “The United States of America, As Represented By” · 30,257 patents in full index Clear search

  1. US 9168297

    Regulation of skin pigmentation by neuregulin-1 (NRG-1)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

  2. US 9169296

    Expression and assembly of human group C rotavirus-like particles and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

  3. US 9168291

    β-mannosylceramide and stimulation of NKT cell anti-tumor immunity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

  4. US 9169182

    Chrysophaentin analogs that inhibit FtsZ protein

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

  5. US 9163258

    Method for the treatment of obesity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted

  6. US 9151762

    Identification of DSG-3 as a biomarker for the detection of metastasis in lymph nodes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted

  7. US 9150926

    Diagnosis and treatment of adrenocortical tumors using human microRNA-483

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted

  8. US 9150644

    Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted

  9. US 9144604

    Vaccine for Shigella

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted

  10. US 9140687

    Renal cell carcinoma biomarkers

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  11. US 9139595

    Biologically active macrolides, compositions, and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  12. US 9133478

    Modified vaccinia Ankara (MVA) virus recombinants comprising heterologous coding sequences inserted into the intergenic regions between essential genes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  13. US 9133480

    Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertion sites

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  14. US 9128080

    Modified T cell receptors and related materials and methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted

  15. US 9127056

    Monospecific and bispecific human monoclonal antibodies targeting insulin-like growth factor II (IGF-II)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted

  16. US 9115371

    Reduction of TGF beta signaling in myeloid cells in the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted

  17. US 9114102

    Method of inhibiting ABCG2 and related treatments

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted

  18. US 9107938

    Methods of selecting and using therapeutic and prophylactic probiotic cultures to reduce bacterial pathogen loads

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted

  19. US 9101601

    Methods of treating or preventing insulin resistance and associated diseases and conditions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted

  20. US 9101600

    Compounds as RORγt modulators and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted

  21. US 9102831

    Process for producing improved zein articles

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted

  22. US 9096653

    Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  23. US 9084819

    Magnetic microstructures for magnetic resonance imaging

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  24. US 9084783

    Thio compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.